Monoclonal antibodies now also authorized for post-exposure prophylaxis of Covid-19 |
Editorial
eMediNexus Coverage from: 
Monoclonal antibodies now also authorized for post-exposure prophylaxis of Covid-19
Dr Veena Aggarwal, Consultant Womens’ Health, MD and Chairperson, IJCP Group & Medtalks Trustee,,  01 August 2021
Coronavirus Live Count Map India

remove_red_eye 1822 Views
COVID-19 Vaccine Updates

Coronavirus Protocols

#Multispeciality

3 Read Comments                

The US FDA has expanded the Emergency Use Authorization (EUA) for the monoclonal antibody cocktail of casirivimab and imdevimab to also include emergency use for post-exposure prophylaxis of individuals exposed to COVID-19 and who are:not fully vaccinated or who are not expected to mount an adequate immune response to complete SARS-CoV-2 vaccination (for example, individuals with immunocompromising conditions including those taking immunosuppressive medications) and have been exposed to an indiv...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now